IP Library Granted Patent US 8,987,474
Granted Patent B2
US 8,987,474 · App. 11/733,023 · Granted Mar 24, 2015

Inhibition of Shp2/PTPN11 protein tyrosine phosphatase by NSC-87877, NSC-117199 and their analogs

Inventors: Jie Wu (Tampa, FL); Nicholas J. Lawrence (Tampa, FL); Said M. Sebti (Tampa, FL); Harshani R. Lawrence (Tampa, FL)
Assignees: University of South Florida; H. Lee Moffitt Cancer Center and Research Institute, Inc.
A61K31/405C07D209/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,987,474
App. No.
11/733,023
Granted
Mar 24, 2015
Kind
B2
Abstract

Compounds and associated methods for inhibiting a protein tyrosine phosphatase. By a combination of experimental and virtual screenings of the NCI Diversity Set chemical library, NSC-87877 and NSC-117199 have been identified as Shp2 PTP inhibitors. Significantly, NSC-87877 is active in cell-based assays and has no detectable off-target effects in the EGF-stimulated Erk 1/2 activation pathway. Additionally, a number of analogs of NSC-117199 have been produced. These analogs exhibit enhanced protein tyrosine phosphatase inhibition and are found to be potent and/or selective inhibitors of Shp1 and/or Shp2 protein tyrosine phosphatases.

Claims (32)

1. A compound having the formula (I):

wherein R 1 is CO 2 H, SO 2 NHCH 2 (C 6 H 4 )—X, SO 2 NHCH 2 (C 6 H 5 ), SO 2 N(CH3) 2 , or SO 2 NHCH 2 (C 6 H 4 )OCH 3 ,

wherein X is one or more moieties selected from the group consisting of chlorine, oxymethyl, fluorine, methyl and morpholine;

wherein R 4 and R 5 are hydrogen;

wherein each of R 2 and R 3 are hydrogen, nitro, or CO 2 H;

R 6 is hydrogen; and

wherein one of R 2 and R 3 is hydrogen and R 2 and R 3 are not concurrently the same functional group.

2. The compound according to claim 1 wherein R 2 or R 3 is nitro.

3. A compound having the formula (II):

wherein R 1 is CO 2 H, SO 2 NHCH 2 (C 6 H 5 ), or SO 2 NHCH 2 C 6 H 4 Cl;

wherein each of R 2 and R 3 are independently hydrogen, nitro, or CO 2 H;

wherein R 4 is hydrogen, or benzyl; and

wherein one of R 2 and R 3 is hydrogen and R 2 and R 3 are not concurrently the same functional group.

4. The compound according to claim 3 wherein R 1 is SO 2 NHCH 2 C 6 H 4 Cl.

5. The compound according to claim 4 wherein R 2 is selected from the group consisting of nitro, and CO 2 H.

6. The compound according to claim 3 wherein R 4 is hydrogen.

7. A compound having the formula (III):

wherein each of R 1 through R 5 are independently hydrogen, nitro, or CO 2 H;

R 6 is hydrogen; and

R 7 is NHCH 2 (C 6 H 4 )—X,

wherein X is one or more moieties selected from the group consisting of hydrogen, fluorine, chlorine, and oxymethyl;

wherein at least one of R 1 through R 5 is not hydrogen.

8. The compound according to claim 7 wherein R 3 through R 6 are hydrogen and each of R 1 and R 2 is selected from the group consisting of nitro and CO 2 H.

9. A compound having the formula (IV):

wherein each of R 1 and R 2 are independently hydrogen, nitro, CO 2 H, or CO 2 CH 3 ;

R 3 through R 5 are hydrogen;

R 6 is hydrogen;

R 7 is NHCH 2 (C 6 H 4 )—X, SO 2 NHCH 2 (C 6 H 5 ); or SO 2 NHCH 2 (C 6 H 4 )OCH 3 ;

wherein X is one or more moieties selected from the group consisting of chlorine, and oxymethyl; and

wherein at least one of R 1 through R 5 is not hydrogen.

10. The compound according to claim 1 wherein R 2 is nitro when R 1 is SO 2 NHCH 2 (C 6 H 4 )—X, SO 2 NHCH 2 (C 6 H 5 ), SO 2 N(CH 3 ) 2 , or SO 2 NHCH 2 (C 6 H 4 )OCH 3 .

11. The compound according to claim 3 wherein R 2 is nitro when R 1 is SO 2 NHCH 2 (C 6 H 5 ), or SO 2 NHCH 2 C 6 H 4 Cl.

Assignments (5)
CONFIRMATORY LICENSE Recorded Nov 25, 2009
From: H. LEE MOFFITT CANCER CTR & RESEARCH INS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023568/0218 →
CONFIRMATORY LICENSE Recorded May 20, 2009
From: H. LEE MOFFITT CANCER CTR & RESEARCH INS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022707/0445 →
CONFIRMATORY LICENSE Recorded Mar 11, 2008
From: H. LEE MOFFITT CANCER CTR & RESEARCH INS`
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020628/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2007
From: WU, JIE; LAWRENCE, NICHOLAS JAMES; SEBTI, SAID M.
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 019270/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2007
From: LAWRENCE, HARSHANI RITHMA
To: H. LEE MOFFITT CANCER CENTER
Reel/Frame 019270/0013 →
Continuity (2)
Provisional Application 60744431 · Apr 7, 2006
Related Publication 20080176309A1 · Jul 24, 2008